Taiwan FDA registration c8ede61ec1abb015a94bdae9b9db93c6
Changying tumor embryo antigen radioimmunoassay reagent
TW: 常盈腫瘤胚胎抗原放射免疫檢驗試劑
Taiwan·Risk Class 2·IMMUNOTECH s.r.o.·Registered Feb 03, 2006 – Feb 03, 2016CancelledRegistration details
- Analysis ID
- c8ede61ec1abb015a94bdae9b9db93c6
- Customs Code
- DHAS0601595801
Company information
- Manufacturer
- IMMUNOTECH s.r.o.
- Manufacturer Country
- Czechia
- Authorized Representative
- WOLCH ENTERPRISES INC.
Product details
- Intended Use
- It is suitable for the immunoradiology analysis of tumor embryonic antigen plasma concentration in vitro.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.6010 腫瘤相關抗原免疫試驗系統
- Import Information
- Input;; Consent letter must be attached to the import (consent from the Atomic Energy Commission must be obtained for each import)
Dates and status
- Registration Date
- Feb 03, 2006
- Expiry Date
- Feb 03, 2016
- Cancellation Date
- Apr 25, 2018
Cancellation information
- Status
- Logged out
- Reason
- 自行鍵入
About this record
Access comprehensive regulatory information for Changying tumor embryo antigen radioimmunoassay reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number c8ede61ec1abb015a94bdae9b9db93c6 and manufactured by IMMUNOTECH s.r.o.. The authorized representative in Taiwan is WOLCH ENTERPRISES INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices